Survival control of malignant lymphocytes by anti-apoptotic MCL-1

被引：35

作者：

Fernandez-Marrero, Y. ^{[1
]}

Spinner, S. ^{[2
]}

Kaufmann, T. ^{[1
]}

Jost, P. J. ^{[2
]}

机构：

[1] Univ Bern, Fac Med, Inst Pharmacol, Bern, Switzerland

[2] Tech Univ Munich, Klinikum Rechts Isar, Med Dept Hematol & Oncol 3, Ismaningerstr 22, D-81675 Munich, Germany

来源：

LEUKEMIA | 2016年 / 30卷 / 11期

基金：

瑞士国家科学基金会;

关键词：

T-CELL LYMPHOMA; BCL-2 FAMILY PROTEINS; NON-HODGKINS-LYMPHOMA; STRUCTURE-GUIDED DESIGN; GENOME-WIDE ANALYSIS; DOWN-REGULATION; IN-VITRO; B-CELLS; ANAPLASTIC LYMPHOMA; SIGNALING PATHWAY;

D O I：

10.1038/leu.2016.213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Programmed apoptotic cell death is critical to maintain tissue homeostasis and cellular integrity in the lymphatic system. Accordingly, the evasion of apoptosis is a critical milestone for the transformation of lymphocytes on their way to becoming overt lymphomas. The anti-apoptotic BCL-2 family proteins are pivotal regulators of the mitochondrial apoptotic pathway and genetic aberrations in these genes are associated with lymphomagenesis and chemotherapeutic resistance. Pharmacological targeting of BCL-2 is highly effective in certain indolent B-cell lymphomas; however, recent evidence highlights a critical role for the BCL-2 family member MCL-1 in several lymphoma subtypes. MCL-1 is recurrently highly expressed in various kinds of cancer including non-Hodgkin's lymphoma of B-and T-cell origin. Moreover, both indolent and aggressive forms of lymphoma require MCL-1 for lymphomagenesis and for their continued survival. This review summarizes the role of MCL-1 in B-and T-cell lymphoma and discusses its potential as a therapeutic target.

引用

页码：2152 / 2159

页数：8

共 100 条

[1] Bcl-2 family of proteins in indolent B-cell non-Hodgkin's lymphoma: Study of 116 cases [J].

Agarwal, B ;

Naresh, KN .

AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (04) :278-282

[2] The landscape of somatic copy-number alteration across human cancers [J].

Beroukhim, Rameen ;

Mermel, Craig H. ;

Porter, Dale ;

Wei, Guo ;

Raychaudhuri, Soumya ;

Donovan, Jerry ;

Barretina, Jordi ;

Boehm, Jesse S. ;

Dobson, Jennifer ;

Urashima, Mitsuyoshi ;

Mc Henry, Kevin T. ;

Pinchback, Reid M. ;

Ligon, Azra H. ;

Cho, Yoon-Jae ;

Haery, Leila ;

Greulich, Heidi ;

Reich, Michael ;

Winckler, Wendy ;

Lawrence, Michael S. ;

Weir, Barbara A. ;

Tanaka, Kumiko E. ;

Chiang, Derek Y. ;

Bass, Adam J. ;

Loo, Alice ;

Hoffman, Carter ;

Prensner, John ;

Liefeld, Ted ;

Gao, Qing ;

Yecies, Derek ;

Signoretti, Sabina ;

Maher, Elizabeth ;

Kaye, Frederic J. ;

Sasaki, Hidefumi ;

Tepper, Joel E. ;

Fletcher, Jonathan A. ;

Tabernero, Josep ;

Baselga, Jose ;

Tsao, Ming-Sound ;

Demichelis, Francesca ;

Rubin, Mark A. ;

Janne, Pasi A. ;

Daly, Mark J. ;

Nucera, Carmelo ;

Levine, Ross L. ;

Ebert, Benjamin L. ;

Gabriel, Stacey ;

Rustgi, Anil K. ;

Antonescu, Cristina R. ;

Ladanyi, Marc ;

Letai, Anthony .

NATURE, 2010, 463 (7283) :899-905

[3] New dimension in therapeutic targeting of BCL-2 family proteins [J].

Besbes, Samaher ;

Mirshahi, Massoud ;

Pocard, Marc ;

Billard, Christian .

ONCOTARGET, 2015, 6 (15) :12862-12871

[4] Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity [J].

Bruncko, Milan ;

Wang, Le ;

Sheppard, George S. ;

Phillips, Darren C. ;

Tahir, Stephen K. ;

Xue, John ;

Erickson, Scott ;

Fidanze, Steve ;

Fry, Elizabeth ;

Hasvold, Lisa ;

Jenkins, Gary J. ;

Jin, Sha ;

Judge, Russell A. ;

Kovar, Peter J. ;

Madar, David ;

Nimmer, Paul ;

Park, Chang ;

Petros, Andrew M. ;

Rosenberg, Saul H. ;

Smith, Morey L. ;

Song, Xiaohong ;

Sun, Chaohong ;

Tao, Zhi-Fu ;

Wang, Xilu ;

Xiao, Yu ;

Zhang, Haichao ;

Tse, Chris ;

Leverson, Joel D. ;

Elmore, Steven W. ;

Souers, Andrew J. .

JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (05) :2180-2194

[5] Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance [J].

Campbell, Kirsteen J. ;

Bath, Mary L. ;

Turner, Marian L. ;

Vandenberg, Cassandra J. ;

Bouillet, Philippe ;

Metcalf, Donald ;

Scott, Clare L. ;

Cory, Suzanne .

BLOOD, 2010, 116 (17) :3197-3207

[6] Parkin Sensitizes toward Apoptosis Induced by Mitochondrial Depolarization through Promoting Degradation of Mcl-1 [J].

Carroll, Richard G. ;

Hollville, Emilie ;

Martin, Seamus J. .

CELL REPORTS, 2014, 9 (04) :1538-1553

[7] Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F [J].

Cencic, Regina ;

Hall, David R. ;

Robert, Francis ;

Du, Yuhong ;

Min, Jaeki ;

Li, Lian ;

Qui, Min ;

Lewis, Iestyn ;

Kurtkaya, Serdar ;

Dingledine, Ray ;

Fu, Haian ;

Kozakov, Dima ;

Vajda, Sandor ;

Pelletier, Jerry .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (03) :1046-1051

[8] Interleukin-7 promotes the survival of human CD4+effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway [J].

Chetoui, Nizar ;

Boisvert, Marc ;

Gendron, Steve ;

Aoudjit, Fawzi .

IMMUNOLOGY, 2010, 130 (03) :418-426

[9] MCL-1 expression in B-cell non-Hodgkin's lymphomas [J].

Cho-Vega, JH ;

Rassidakis, GZ ;

Admirand, JH ;

Oyarzo, M ;

Ramalingam, P ;

Paraguya, A ;

McDonnell, TJ ;

Amin, HM ;

Medeiros, LJ .

HUMAN PATHOLOGY, 2004, 35 (09) :1095-1100

[10] MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies [J].

Choudhary, G. S. ;

Al-Harbi, S. ;

Mazumder, S. ;

Hill, B. T. ;

Smith, M. R. ;

Bodo, J. ;

Hsi, E. D. ;

Almasan, A. .

CELL DEATH & DISEASE, 2015, 6 :e1593-e1593

← 1 2 3 4 5 6 7 8 9 10 →